VK
Venkata Krishna Murty Ponnapalli
About Venkata Krishna Murty Ponnapalli
Data last updated:
Venkata Krishna Murty Ponnapalli was a Director at Allianz Biosciences Private Limited (2015–2019), Director at Tablets (India) Ltd (2009–2010) and Director at Healkraft Pharma (India) Private Limited (2010–2015), and held 1 more directorship. The companies operate in Pharma.
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Allianz Biosciences Private Limited U24231TN2003PTC050203 | Director | 01 Aug 2015 | 2003 | ₹87.53 Cr (FY 2022) | Active |
 Tablets (India) Ltd U24231TN1938PLC002883 | Director | 01 Nov 2009 | 1938 | ₹667 Cr (FY 2025) | Active |
 Healkraft Pharma (India) Private Limited U24231TN1981PTC009016 | Director | 21 Apr 2010 | 1981 | ₹25.01 Cr (FY 2025) | Active |
| Tablets Globalcare Private Limited U24110TN2018PTC124933 | Director | 28 Sep 2018 | 2018 | ₹39.2 Lakh (FY 2025) | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Venkata Krishna Murty Ponnapalli
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Venkata Krishna Murty Ponnapalli
Venkata Krishna Murty Ponnapalli was first appointed on 01 Nov 2009 as Director at Tablets (India) Ltd. The most recent appointment on record is 28 Sep 2018 at Tablets Globalcare Private Limited.
Venkata Krishna Murty Ponnapalli held 4 earlier board appointments: Allianz Biosciences Private Limited (Director, 01 Aug 2015 to 23 Oct 2019); Tablets (India) Ltd (Director, 01 Nov 2009 to 21 Apr 2010); Healkraft Pharma (India) Private Limited (Director, 21 Apr 2010 to 22 Jun 2015); Tablets Globalcare Private Limited (Director, 28 Sep 2018 to 21 Oct 2019).